METTL3 and gastrointestinal stromal tumor: Elevated METTL3 levels were detected in imatinib‐resistant gastrointestinal stromal tumor (GIST) cells and tissue samples which insert the m6A modification to the 5′‐UTR of its downstream target MRP1 mRNA.